Product Information
DIAZEPAM 20 MG RECTAL GEL (2PK) is a generic product labeled by Oceanside Pharmaceuticals, priced at $236.6004 per EA under NDC 68682065520. Its NADAC has been published 416 times since Oct 18, 2017.
FDA first approved this application on Jul 29, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/4mL
Manufacturer
Oceanside PharmaceuticalsNDC
68682065520
Classification
Generic
Dosage Form
GEL
Route
RECTAL
Effective Date
9/17/2025
Active Ingredients
DIAZEPAMApproval Type
Authorized Generic (NDA)
FDA Application
NDA020648FDA Approved
7/29/1997
TE Code
AB
On Market Since
7/29/1997
Pharmacological Classes
Price Statistics
The NADAC for DIAZEPAM 20 MG RECTAL GEL (2PK) has been published 416 times since Oct 18, 2017, and over the history we have for it it has declined 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $236.6004 per EA |
|---|---|
| All-time high | $285.6029 (Oct 13, 2021) |
| All-time low | $191.0314 (May 22, 2024) |
| Median price | $258.3200 |
| Average price | $255.5165 |
| Largest weekly change | -26.4% (May 22, 2024) |
| Weeks tracked | 416 |
| Tracking since | Oct 18, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-4.9%
5Y
-17.2%
All
-3.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIAZEPAM 20 MG RECTAL GEL (2PK)?
The current National Average Drug Acquisition Cost (NADAC) for DIAZEPAM 20 MG RECTAL GEL (2PK), manufactured by Oceanside Pharmaceuticals, is $236.6004 per EA (NDC 68682065520), effective Oct 1, 2025.
How has the price of DIAZEPAM 20 MG RECTAL GEL (2PK) changed over time?
Over the history we have for it, the NADAC for DIAZEPAM 20 MG RECTAL GEL (2PK) has declined 3.6%. It has been tracked across 416 weekly CMS publications since Oct 18, 2017.
What are the highest and lowest recorded NADAC prices for DIAZEPAM 20 MG RECTAL GEL (2PK)?
Since Oct 18, 2017, the NADAC for DIAZEPAM 20 MG RECTAL GEL (2PK) has ranged from a low of $191.0314 (May 22, 2024) to a high of $285.6029 (Oct 13, 2021), with a median of $258.3200 per EA.
Are there cheaper alternatives to DIAZEPAM 20 MG RECTAL GEL (2PK)?
No other NADAC-published product currently shares the active ingredient and strength of DIAZEPAM 20 MG RECTAL GEL (2PK) in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIAZEPAM 20 MG RECTAL GEL (2PK)?
DIAZEPAM 20 MG RECTAL GEL (2PK) (NDC 68682065520) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.